
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
AXON Neuroscience is a clinical-stage biotech company founded in 1999 with a specialized team of researchers focused exclusively on tau immunotherapies and tau diagnostic platforms. AXON has identified and wholly owns several compounds which are being investigated as potentially disease-modifying therapies for the treatment of Alzheimers disease and other tauopathies. The two lead compounds are the active vaccine AADvac1 and the monoclonal antibody AADvac2. The tau vaccine AADvac1 has potential to be the first breakthrough therapy to address Alzheimers disease and help millions of people suffering from the devastating disease. Axon is also developing a suite of diagnostic assays to...
Disease modifying pharmaceuticals and diagnostic methods for alzheimer’s disease
Axon neuroscience operates in the Biotechnology research industry.
Axon neuroscience's revenue is 11m - 100m
Axon neuroscience has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.